Tackling Policy Issues to Ensure Patient Access to Testing & Facilitate Longitudinal Monitoring
- Assessing the limitations of the current policy environment for liquid biopsies, especially for serial monitoring
- How to influence and overcome policy issues preventing patient access to therapeutics
- What are the realistic milestones to hit to expedite better patient access to better drug-diagnostics?